FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1289-1292 March 27, 2003 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Khan, K. PubMed Citation

To the Editor: We applaud the rigorous decision analysis by Khan et al. (Dec. 5 issue),¹ who demonstrated the cost effectiveness of screening and treating recent immigrants from countries where tuberculosis is prevalent for latent tuberculosis infection. The investigators also attempted to identify the best treatment regimens for latent tuberculosis infection in various populations from developing countries, on the basis of drug-resistance patterns. However, the differences in direct costs and health benefits among these regimens were relatively small and should be interpreted cautiously. The comparisons were limited, in that the estimates of drug resistance for certain countries (derived from data . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.